Home » Topics » BioWorld Science

BioWorld Science
RSS

Targeting IL1R signaling may abrogate obesity-induced colon cancer

Nov. 2, 2018

Topline results reported from CLARITY phase II study of pimavanserin for MDD

Nov. 2, 2018

PAR and Parkinson's

Nov. 2, 2018

Daiichi Sankyo discontinues development of intradermal seasonal influenza vaccine

Nov. 2, 2018

Positive interim data presented from phase IIb study of MDNA-55 in recurrent glioblastoma

Nov. 2, 2018

ILDONG Pharmaceutical discovers farnesoid X receptor agonists

Nov. 2, 2018

Roche patents antibacterial macrocyclic oligopeptides

Nov. 2, 2018

Biogen describes new Bruton tyrosine kinase inhibitors

Nov. 2, 2018

Greater clinical benefit observed in breast cancers treated with pegilodecakin and SOC chemotherapy

Nov. 2, 2018

AbbVie presents preliminary phase I data for ABBV-368

Nov. 2, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.